Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Klain

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cancers|September 10, 2021
Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid CancerMichele Klain, Emilia Zampella, Leandra Piscopo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2026
Peptide receptor radionuclide therapy (PRRT) in high grade neuroendocrine neoplasms: a systematic review and meta-analysisEmilia Zampella, Leandra Piscopo, Roberta Green, et al.
Clinical Nuclear Medicine|December 30, 2014
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patientsLeonardo Pace, Michele Klain, Barbara Salvatore, et al.
Thyroid : Official Journal of the American Thyroid Association|September 13, 2002
Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinomaAnne Bachelot, Anne Françoise Cailleux, Michele Klain, et al.
Endocrine|January 24, 2023
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancerEmilia Zampella, Leandra Piscopo, Mariarosaria Manganelli, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Pancreatic Neuroendocrine Tumors: From Benchside to Surgical TreatmentGiovanni Conzo, Federico Maria Mongardini, Maddalena Paolicelli, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid CancerMichele Klain, Carmela Nappi, Marina De Risi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2020
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challengeMichele Klain, Carmela Nappi, Simone Maurea, et al.
Cancers|July 14, 2023
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine NeoplasmsLeandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Clinical Endocrinology|July 26, 2011
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinomaRoberto Nersita, Antonio Matrone, Michele Klain, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cancers|September 10, 2021
Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid CancerMichele Klain, Emilia Zampella, Leandra Piscopo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2026
Peptide receptor radionuclide therapy (PRRT) in high grade neuroendocrine neoplasms: a systematic review and meta-analysisEmilia Zampella, Leandra Piscopo, Roberta Green, et al.
Clinical Nuclear Medicine|December 30, 2014
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patientsLeonardo Pace, Michele Klain, Barbara Salvatore, et al.
Thyroid : Official Journal of the American Thyroid Association|September 13, 2002
Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinomaAnne Bachelot, Anne Françoise Cailleux, Michele Klain, et al.
Endocrine|January 24, 2023
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancerEmilia Zampella, Leandra Piscopo, Mariarosaria Manganelli, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Pancreatic Neuroendocrine Tumors: From Benchside to Surgical TreatmentGiovanni Conzo, Federico Maria Mongardini, Maddalena Paolicelli, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid CancerMichele Klain, Carmela Nappi, Marina De Risi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2020
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challengeMichele Klain, Carmela Nappi, Simone Maurea, et al.
Cancers|July 14, 2023
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine NeoplasmsLeandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Clinical Endocrinology|July 26, 2011
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinomaRoberto Nersita, Antonio Matrone, Michele Klain, et al.
Pageof 8